Quest Diagnostics (DGX) Total Liabilities (2009 - 2026)

Quest Diagnostics has disclosed Total Liabilities across 18 years of filings, most recently posting $9.3 billion for Q1 2026.

• Total Liabilities for Q1 2026 came in at $9.3 billion, up 5.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.3 billion (up 5.34% YoY), and the FY2025 annual result was $9.1 billion, down 3.05% from the prior year.
• Total Liabilities came in at $9.3 billion for Q1 2026 at Quest Diagnostics, up from $9.1 billion in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $9.3 billion in Q4 2024 to a low of $6.7 billion in Q1 2023.
• The 5-year median for Total Liabilities is $7.5 billion (2024), against an average of $7.9 billion.
• Across the five-year window, Total Liabilities decreased 4.57% in 2023 and surged 31.84% in 2024, its largest moves.
• Quest Diagnostics' Total Liabilities stood at $6.9 billion in 2022, then increased by 11.19% to $7.7 billion in 2023, then advanced by 21.61% to $9.3 billion in 2024, then slipped by 3.05% to $9.1 billion in 2025, then climbed by 2.78% to $9.3 billion in 2026.
• The last three Total Liabilities figures came in at $9.3 billion (Q1 2026), $9.1 billion (Q4 2025), and $8.9 billion (Q3 2025), per Business Quant data.